199 related articles for article (PubMed ID: 21463219)
1. Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery.
Agüeros M; Espuelas S; Esparza I; Calleja P; Peñuelas I; Ponchel G; Irache JM
Expert Opin Drug Deliv; 2011 Jun; 8(6):721-34. PubMed ID: 21463219
[TBL] [Abstract][Full Text] [Related]
2. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles.
Agüeros M; Zabaleta V; Espuelas S; Campanero MA; Irache JM
J Control Release; 2010 Jul; 145(1):2-8. PubMed ID: 20347897
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
Zabaleta V; Ponchel G; Salman H; Agüeros M; Vauthier C; Irache JM
Eur J Pharm Biopharm; 2012 Aug; 81(3):514-23. PubMed ID: 22516136
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin/poly(anhydride) nanoparticles as drug carriers for the oral delivery of atovaquone.
Calvo J; Lavandera JL; Agüeros M; Irache JM
Biomed Microdevices; 2011 Dec; 13(6):1015-25. PubMed ID: 21773725
[TBL] [Abstract][Full Text] [Related]
5. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles.
Calleja P; Espuelas S; Vauthier C; Ponchel G; Irache JM
J Pharm Sci; 2015 Sep; 104(9):2877-86. PubMed ID: 25600579
[TBL] [Abstract][Full Text] [Related]
6. Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel.
Agüeros M; Ruiz-Gatón L; Vauthier C; Bouchemal K; Espuelas S; Ponchel G; Irache JM
Eur J Pharm Sci; 2009 Nov; 38(4):405-13. PubMed ID: 19765652
[TBL] [Abstract][Full Text] [Related]
7. Oral delivery of camptothecin using cyclodextrin/poly(anhydride) nanoparticles.
Huarte J; Espuelas S; Lai Y; He B; Tang J; Irache JM
Int J Pharm; 2016 Jun; 506(1-2):116-28. PubMed ID: 27102993
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-β-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus.
Zhang D; Pan X; Wang S; Zhai Y; Guan J; Fu Q; Hao X; Qi W; Wang Y; Lian H; Liu X; Wang Y; Sun Y; He Z; Sun J
Mol Pharm; 2015 Jul; 12(7):2337-51. PubMed ID: 26024817
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.
Soares AF; Carvalho Rde A; Veiga F
Nanomedicine (Lond); 2007 Apr; 2(2):183-202. PubMed ID: 17716120
[TBL] [Abstract][Full Text] [Related]
10. Model predicting impact of complexation with cyclodextrins on oral absorption.
Gamsiz ED; Thombre AG; Ahmed I; Carrier RL
Biotechnol Bioeng; 2013 Sep; 110(9):2536-47. PubMed ID: 23592239
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
Harde H; Das M; Jain S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated cyclodextrin-polyanhydride nanoparticles.
Al-Heibshy FNS; Başaran E; Arslan R; Öztürk N; Vural İ; Demirel M
Drug Dev Ind Pharm; 2019 Oct; 45(10):1635-1645. PubMed ID: 31342792
[No Abstract] [Full Text] [Related]
13. Modeling the influence of cyclodextrins on oral absorption of low-solubility drugs: I. Model development.
Gamsiz ED; Miller L; Thombre AG; Ahmed I; Carrier RL
Biotechnol Bioeng; 2010 Feb; 105(2):409-20. PubMed ID: 19725042
[TBL] [Abstract][Full Text] [Related]
14. Pegylated poly(anhydride) nanoparticles for oral delivery of docetaxel.
Ruiz-Gatón L; Espuelas S; Larrañeta E; Reviakine I; Yate LA; Irache JM
Eur J Pharm Sci; 2018 Jun; 118():165-175. PubMed ID: 29597043
[TBL] [Abstract][Full Text] [Related]
15. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and antitumor efficacy of paclitaxel-cyclodextrin complexes loaded in mucus-penetrating nanoparticles for oral administration.
Calleja P; Espuelas S; Corrales L; Pio R; Irache JM
Nanomedicine (Lond); 2014 Jul; 9(14):2109-21. PubMed ID: 24471503
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles.
Yoncheva K; Guembe L; Campanero MA; Irache JM
Int J Pharm; 2007 Apr; 334(1-2):156-65. PubMed ID: 17118588
[TBL] [Abstract][Full Text] [Related]
18. Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation.
Dahmani FZ; Yang H; Zhou J; Yao J; Zhang T; Zhang Q
Eur J Pharm Sci; 2012 Aug; 47(1):179-89. PubMed ID: 22683386
[TBL] [Abstract][Full Text] [Related]
19. Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles.
Agüeros M; Areses P; Campanero MA; Salman H; Quincoces G; Peñuelas I; Irache JM
Eur J Pharm Sci; 2009 Jun; 37(3-4):231-40. PubMed ID: 19491010
[TBL] [Abstract][Full Text] [Related]
20. Coencapsulation of cyclodextrins into poly(anhydride) nanoparticles to improve the oral administration of glibenclamide. A screening on C. elegans.
Lucio D; Martínez-Ohárriz MC; González-Navarro CJ; Navarro-Herrera D; González-Gaitano G; Radulescu A; Irache JM
Colloids Surf B Biointerfaces; 2018 Mar; 163():64-72. PubMed ID: 29277019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]